The GHK-Cu hair loss headline may have the wrong name.
Looking up ClinicalTrials.gov GHK-Cu hair loss claims can send you through a lot of similar names. Two papers help explain the confusion. Neither tested GHK-Cu alone as a hair-loss treatment in people.

Blend
The whole mix was tested.
The human hair trial tested a scalp blend of GHK and 5-aminolevulinic acid, another ingredient. GHK is the peptide without the copper. The six-month study involved 45 men with male-pattern hair loss; it wasn’t a test of every reason someone might lose hair.
Hair counts rose more with two strengths of the blend than with the comparison lotion. Hair thickness didn’t show a significant difference. That’s a useful distinction if “thicker hair” is the claim that caught your eye. The study also reported no adverse events, within this small trial.
There was no group using GHK-Cu alone. The particular blend keeps the credit for the result; we can’t award it to an ingredient the study didn’t test on its own.
Ex vivo
Tissue studied outside the person.
The follicle paper often linked in hair discussions used AHK-Cu. Its first building block differs from GHK-Cu’s. It’s a related copper peptide, but treating the two names as interchangeable would misdescribe the experiment.
Researchers saw growth effects in isolated human follicles and supporting cells. Human tissue makes the finding interesting. The word “human” doesn’t mean people received a scalp treatment, though. This work happened outside their bodies, so it couldn’t measure whether their hair loss improved.
A headline about human hair growth can mean an isolated follicle. Checking where the hair was makes the finding much easier to understand.
Trial record
A study plan isn’t an answer.
When a ClinicalTrials.gov record is offered as proof, look for the actual ingredients and the results. A description of planned work can explain what researchers want to test. It can’t show that the treatment worked before results exist.
The published human paper linked here is the blend study. We aren’t presenting it as a registered trial of GHK-Cu alone. If you have a record or screenshot in front of you, compare its full ingredient name with the one in the claim. Even one changed letter can send you to a different paper.
A useful question for a clinician is what evidence fits this exact preparation and this cause of hair loss. Personal reports can raise questions too, but they don’t fill that gap.